TrialEndocrine-related cancer2022
Serum markers, obesity and prostate cancer risk: results from the prostate cancer prevention trial.
Cindy H Chau et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
15 papers cite it
this paperpooled itcites it